Skip to main content
. Author manuscript; available in PMC: 2016 Feb 10.
Published in final edited form as: Tuberculosis (Edinb). 2012 Jul 10;92(5):397–403. doi: 10.1016/j.tube.2012.06.003

Table 1.

Adverse events on treatment with second-line drugs (N=823)

Adverse event Number (percent*)
Nausea 540 (65.6)
Diarrhea 249 (30.3)
Ototoxicity (hearing disturbances) 130 (15.8)
Headache 95/602** (11.5)
Hypokalemia 99/221** (14.9)
Peripheral neuropathy 76 (9.2)
Hypothyroidism 40 (4.9)
Seizure 39 (4.7)
Psychosis 35/379** (4.3)
Hepatitis 19 (2.3)
Renal insufficiency (elevated creatinine) 15/602** (1.8)
*

Percentage from total 823 unless states otherwise.

**

Denominator is number of patients with available data on particular adverse event.